SNDL Inc.

NASDAQ: SNDL · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Calgary, ABCIK 0001766600Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 76DQ —GM —SS 66

v0.1 · 35/100 weight · pillars only

↑ workforce scale, balance-sheet leverage · ↓ filing timeliness, listing tenure

Methodology →

Revenue TTM

$677.9M

Rev growth YoY (TTM)

+1.6%

Net income (FY)

-$11.3M

Employees

2,604

Market cap

$357.9M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$11.3M-15.8M CAD2025

Total assets$974.7M1.3B CAD2025

Liabilities$171.3M234.7M CAD2025

Revenue by segment

Filed disclosures · FY2022

By product

Cannabis100%

By geography

Not disclosed.

The read

SNDL Inc. earned -$11.3M in FY2025 net income.

Peers · Healthcare

Standard BioTools Inc.61C Editas Medicine, Inc.45D C4 Therapeutics, Inc.50D Keros Therapeutics, Inc.72B

Key facts

CEOZachary Ryan George

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersCalgary, AB

ExchangeNASDAQ: SNDL

Employees2,604

IPO date2019-08-01

Latest filings

6-K2026-05-28 6-K2026-04-29 6-K2026-04-29 6-K2026-04-15 6-K2026-03-30 40-F2026-03-12 6-K2026-03-12 6-K2026-02-19

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.